Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering.
about
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysisStatins and fibrates for preventing melanomaTreatment of the elderly post-myocardial infarction patientLDL Cholesterol Goal Attainment in Hypercholesterolemia: CEPHEUS Indonesian SurveyDifferential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sitesAre the elderly different? Factors influencing mortality after percutaneous coronary intervention with stent implantation.Using routinely collected prescribing data to determine drug persistence for the purpose of pharmacovigilance.Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cellsLipid-lowering drugs in lupus: an unexplored therapeutic intervention.Simvastatin: a review.Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapyStatins and prostate cancer risk: a case-control study.Statins in the 21st century: end of the simple story?Pharmacologic therapy of lipid disorders in the elderly.The complex interplay between cholesterol and prostate malignancy.Lipid-lowering therapy in older personsTreatment of children with familial hypercholesterolemia.Elevated K-ras activity with cholestyramine and lovastatin, but not konjac mannan or niacin in lung--importance of mouse strainStatins: past and present.Simvastatin may induce insulin resistance through a novel fatty acid mediated cholesterol independent mechanismAtorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-KrasG12D/+ mice.Benefits and risks assessment of simvastatin in familial hypercholesterolaemia.Fluvastatin inhibits AGE-induced cell proliferation and migration via an ERK5-dependent Nrf2 pathway in vascular smooth muscle cells.The HMG-CoA reductase pathway, statins and angioprevention.Cardiac autonomic testing and treating heart disease. "A clinical perspective".Modulation of lipid rafts by Omega-3 fatty acids in inflammation and cancer: implications for use of lipids during nutrition support.Mortality in COPD: inevitable or preventable? Insights from the cardiovascular arena.Simvastatin-induced compartmentalisation of doxorubicin sharpens up nuclear topoisomerase II inhibition in human rhabdomyosarcoma cells.Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin Therapy: 20-Year Follow-Up of West of Scotland Coronary Prevention Study.Management of hyperlipidemia with statins in the older patient.Determining the cost-effectiveness of preventing cardiovascular disease: are estimates calculated over the duration of a clinical trial adequate?Simvastatin: two decades in a circle.Long-term medication adherence after myocardial infarction: experience of a communityStatins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes.Mechanisms of simvastatin-induced vasodilatation of rat superior mesenteric arteries.Pleiotropic effects of simvastatin in physically trained ovariectomized rats.Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.Vascular memory: can we broaden the concept of the metabolic memory?The ezetimibe controversy - can this be resolved by comparing the clinical trials with simvastatin and ezetimibe alone and together?Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates.
P2860
Q24194514-6541B87D-AF5F-4A02-9661-852FB8F24E79Q24245521-738419B7-10B6-42FD-B631-CE6326A02577Q28191018-C7828205-FF5B-4CF4-A8D8-A1A95065E6BFQ28468717-6A07F510-0E18-4E2B-B00E-06535E0AA1C9Q28478551-5E761F75-83F2-4431-A586-08BB8D2E04E2Q30318112-91751D08-AC35-485B-A50A-42C0E9837108Q33558310-0F908769-19EF-4933-8511-0B9AA5080BD0Q34164712-4ABB4CD5-4D9D-4246-9F36-A76A4B192F3EQ34227152-2DC04FE5-74B5-45C0-8BAA-D351F85939E5Q34372227-75DDA01F-4739-4AB8-A945-55BA5146E0EDQ34429244-D8A15A50-0E58-49D6-A54E-103DE90CEE1AQ34433638-56E4F35C-9A46-4768-91EB-F96A89EC5329Q34481748-7614EF53-BF2D-4010-B8E2-0D240EE81212Q34714765-F0B61948-CA39-468E-9A51-C73DE1FCE1A6Q35137013-B0E9CD20-350D-4E99-8FE2-1CEDEB44C9C2Q35232239-E3F7DAB2-A8B0-482B-8DF7-C00FB1CD84D0Q35696538-CB6CF0EB-22A9-45D1-8719-CACD54352D9BQ35745160-E21AB027-FF7E-45D6-8759-77071CEBA6C2Q35936339-4FE6FD27-CD04-4A63-ABF0-738484061D5FQ36034049-E6987598-EF79-4A5C-BA33-C1BE1E5F3433Q36035654-A460A7B2-16FC-4783-94D0-2F50A57C3F70Q36081978-D5B5AA6A-2742-41BD-84C7-68421D697E03Q36380900-7164DCA2-AC56-4D24-9DFE-BA0A585C7C4BQ36414196-E80A9AC4-A0C2-4CC7-B64B-935593788D44Q36641707-D8EF0D4B-9CAF-4F4E-82B2-4187E8A85BF4Q36715129-AAAEF540-4E1B-4D93-9396-FAD27494007FQ36742804-3CDDFBB5-E59C-4B02-9C50-5A2428C02BEEQ36913097-B318D5E5-144C-4F6F-8E4C-8235B2570624Q36973367-B82D2B98-7D4A-4C4A-BD1C-3117017D9823Q37018964-AF27540D-40D0-4C17-ACFB-D0F096A9E6C9Q37100588-8BC56EF0-32EE-4D89-ADEE-2E5377A99A54Q37165690-BDB890BE-8E4B-45D7-8415-3B7DE03F0BD4Q37166857-3BDA6EAC-FA29-4DD1-B705-8F3FBB79087EQ37179559-B976499D-3F68-42CA-A77A-F9C5FE05AF22Q37288422-44D626AC-77ED-47AD-8F40-9C0815D2865AQ37371450-42B30258-F8BE-41E3-BDF8-5C8BC0648357Q37734257-E879F700-C974-4EA2-9C04-8B8136A26F0FQ38006502-EE91B028-313B-46B4-BF39-8A0628980D73Q38020942-3B516DE2-64FE-4A06-85BA-99D6D0081CFBQ38147841-8BDAB64B-1D90-4542-9BD5-95EA14D60E17
P2860
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Follow-up study of patients ra ...... (4S) of cholesterol lowering.
@ast
Follow-up study of patients ra ...... (4S) of cholesterol lowering.
@en
type
label
Follow-up study of patients ra ...... (4S) of cholesterol lowering.
@ast
Follow-up study of patients ra ...... (4S) of cholesterol lowering.
@en
prefLabel
Follow-up study of patients ra ...... (4S) of cholesterol lowering.
@ast
Follow-up study of patients ra ...... (4S) of cholesterol lowering.
@en
P2093
P1476
Follow-up study of patients ra ...... (4S) of cholesterol lowering.
@en
P2093
Faergeman O
Haghfelt T
Kristianson J
Miettinen T
Pedersen TR
Strandberg TE
P304
P356
10.1016/S0002-9149(00)00910-3
P407
P577
2000-08-01T00:00:00Z